Certified by Founder Lodge
Parkwalk Advisors
United Kingdom - King's Cross, England
INVESTOR
1 Disclosed Funding Rounds $50,500,000
43 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Parkwalk is one of the UK’s leading growth fund managers backing world-changing technologies emerging out of UK universities and research institutions with the aim of delivering world-class r
| Company | Date | Round | Raised |
|---|---|---|---|
 Wayland Additive |
April, 20 ,2023 | Unknown | $5,717,000 |
 Mogrify |
October, 03 ,2023 | Series A | $10,000,000 |
 PervasID |
November, 29 ,2024 | Unknown | $4,126,736 |
 RoboK |
June, 30 ,2023 | Unknown | $2,100,000 |
 Entia |
August, 02 ,2023 | Unknown | $12,000,000 |
 AccelerComm Ltd |
May, 12 ,2023 | Series B | $26,906,712 |
| AccelerComm Ltd |
May, 12 ,2023 | Series B | $26,906,712 |
 Quantum Motion |
February, 22 ,2023 | Unknown | $50,500,000 |
 Diffblue |
October, 31 ,2024 | Unknown | $6,300,000 |
| Entia |
August, 02 ,2023 | Unknown | $12,000,000 |
| Diffblue |
October, 31 ,2024 | Unknown | $6,300,000 |
 Phasecraft |
August, 16 ,2023 | Series A | $16,559,000 |
| RoboK |
June, 30 ,2023 | Unknown | $2,100,000 |
 PharmEnable |
May, 23 ,2023 | Pre Series A | $7,500,000 |
| Wayland Additive |
April, 20 ,2023 | Unknown | $5,717,000 |
| RoboK |
June, 30 ,2023 | Unknown | $2,100,000 |
| PervasID |
November, 29 ,2024 | Unknown | $4,126,736 |
| Diffblue |
October, 31 ,2024 | Unknown | $6,300,000 |
| Entia |
August, 02 ,2023 | Unknown | $12,000,000 |
| PervasID |
November, 29 ,2024 | Unknown | $4,126,736 |
| AccelerComm Ltd |
May, 12 ,2023 | Series B | $26,906,712 |
| Entia |
August, 02 ,2023 | Unknown | $12,000,000 |
| Diffblue |
October, 31 ,2024 | Unknown | $6,300,000 |
 Trismik |
September, 26 ,2025 | Pre-Seed | $2,936,967 |
| Phasecraft |
August, 16 ,2023 | Series A | $16,559,000 |
| Phasecraft |
August, 16 ,2023 | Series A | $16,559,000 |
| PharmEnable |
May, 23 ,2023 | Pre Series A | $7,500,000 |
 Scripta Therapeutics |
November, 18 ,2025 | Seed | $12,000,000 |
| RoboK |
June, 30 ,2023 | Unknown | $2,100,000 |
| Mogrify |
October, 03 ,2023 | Series A | $10,000,000 |
| Diffblue |
October, 31 ,2024 | Unknown | $6,300,000 |
| Diffblue |
October, 31 ,2024 | Unknown | $6,300,000 |
| PervasID |
November, 29 ,2024 | Unknown | $4,126,736 |
| PervasID |
November, 29 ,2024 | Unknown | $4,126,736 |
| Entia |
August, 02 ,2023 | Unknown | $12,000,000 |
 Semarion |
April, 02 ,2026 | Unknown | $3,800,000 |
| Trismik |
September, 26 ,2025 | Pre-Seed | $2,936,967 |
| Phasecraft |
August, 16 ,2023 | Series A | $16,559,000 |
| Scripta Therapeutics |
November, 18 ,2025 | Seed | $12,000,000 |
| Mogrify |
October, 03 ,2023 | Series A | $10,000,000 |
| Diffblue |
October, 31 ,2024 | Unknown | $6,300,000 |
| PervasID |
November, 29 ,2024 | Unknown | $4,126,736 |
| Semarion |
April, 02 ,2026 | Unknown | $3,800,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Moonbounce | $12,000,000 | (Apr 7, 2026)
Insight Health AI, Inc. | $11,000,000 | (Apr 7, 2026)
Miravoice | $6,300,000 | (Apr 7, 2026)
Stipple Bio | $100,000,000 | (Apr 7, 2026)
Noon | $44,000,000 | (Apr 7, 2026)
